These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22149323)

  • 21. Psychometric properties of a sleep questionnaire for use in individuals with intellectual disabilities.
    Maas AP; Didden R; Korzilius H; Braam W; Collin P; Smits MG; Curfs LM
    Res Dev Disabil; 2011; 32(6):2467-79. PubMed ID: 21840166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brief Version of Caffeine Expectancy Questionnaire in Brazil.
    Mendes GF; Reis CEG; Nakano EY; Zandonadi RP
    Front Nutr; 2021; 8():695385. PubMed ID: 34277689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of an adolescent smoking consequences questionnaire.
    Lewis-Esquerre JM; Rodrigue JR; Kahler CW
    Nicotine Tob Res; 2005 Feb; 7(1):81-90. PubMed ID: 15804680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preliminary validation of the French translation of anxiety sensibility index-revised (ASI-R)].
    Bouvard M; Ayxères-Vighetto A; Dupont H; Aupetit J; Portalier S; Arrindell W
    Encephale; 2003; 29(2):157-64. PubMed ID: 14567167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of self-efficacy and expectancy measures for benzodiazepines.
    Parr JM; Kavanagh DJ; Young RM; Connor JP
    Addict Behav; 2009 Sep; 34(9):751-6. PubMed ID: 19482437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug use expectancies among nonabstinent community cocaine users.
    Hayaki J; Anderson BJ; Stein MD
    Drug Alcohol Depend; 2008 Apr; 94(1-3):109-15. PubMed ID: 18078722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of repeated doses of caffeine on performance and alertness: new data and secondary analyses.
    Hewlett P; Smith A
    Hum Psychopharmacol; 2007 Aug; 22(6):339-50. PubMed ID: 17514640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Construct validation study of the Relationship Scales Questionnaire (RSQ) on an adult sample].
    Guédeney N; Fermanian J; Bifulco A
    Encephale; 2010 Feb; 36(1):69-76. PubMed ID: 20159199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endorsement of DSM-IV dependence criteria among caffeine users.
    Hughes JR; Oliveto AH; Liguori A; Carpenter J; Howard T
    Drug Alcohol Depend; 1998 Oct; 52(2):99-107. PubMed ID: 9800139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine dependence, use of illegal drugs and psychiatric morbidity.
    Martínez-Ortega JM; Jurado D; Martínez-González MA; Gurpegui M
    Addict Behav; 2006 Sep; 31(9):1722-9. PubMed ID: 16457964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should caffeine abuse, dependence, or withdrawal be added to DSM-IV and ICD-10?
    Hughes JR; Oliveto AH; Helzer JE; Higgins ST; Bickel WK
    Am J Psychiatry; 1992 Jan; 149(1):33-40. PubMed ID: 1728182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Cannabis Effects Expectancy Questionnaire-Medical (CEEQ-M): Preliminary psychometric properties and longitudinal validation within a clinical trial.
    Weiss JH; Tervo-Clemmens B; Potter KW; Evins AE; Gilman JM
    Psychol Assess; 2023 Aug; 35(8):659-673. PubMed ID: 37289502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeine expectancies but not caffeine reduce depletion-induced aggression.
    Denson TF; Jacobson M; von Hippel W; Kemp RI; Mak T
    Psychol Addict Behav; 2012 Mar; 26(1):140-4. PubMed ID: 21766974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor structure of the Conners Adult ADHD Rating Scale (CAARS) for substance users.
    Cleland C; Magura S; Foote J; Rosenblum A; Kosanke N
    Addict Behav; 2006 Jul; 31(7):1277-82. PubMed ID: 16169157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is caffeine addictive? The most widely used psychoactive substance in the world affects same parts of the brain as cocaine].
    Daly JW; Holmén J; Fredholm BB
    Lakartidningen; 1998 Dec; 95(51-52):5878-83. PubMed ID: 9889511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of the Stimulant Relapse Risk Scale for drug abusers in Japan.
    Ogai Y; Haraguchi A; Kondo A; Ishibashi Y; Umeno M; Kikumoto H; Hori T; Komiyama T; Kato R; Aso K; Asukai N; Senoo E; Ikeda K
    Drug Alcohol Depend; 2007 May; 88(2-3):174-81. PubMed ID: 17118576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and psychometric evaluation of the Bipolar Functional Status Questionnaire (BFSQ).
    Goldberg JF; McLeod LD; Fehnel SE; Williams VS; Hamm LR; Gilchrist K
    Bipolar Disord; 2010 Feb; 12(1):32-44. PubMed ID: 20148865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychometric properties of the Drug Use Disorders Identification Test (DUDIT) with substance abusers in outpatient and residential treatment.
    Voluse AC; Gioia CJ; Sobell LC; Dum M; Sobell MB; Simco ER
    Addict Behav; 2012 Jan; 37(1):36-41. PubMed ID: 21937169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Caffeine--common ingredient in a diet and its influence on human health].
    Wierzejska R
    Rocz Panstw Zakl Hig; 2012; 63(2):141-7. PubMed ID: 22928360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].
    Chabrol H; Mabila JD; Chauchard E; Mantoulan R; Rousseau A
    Encephale; 2008 Jan; 34(1):8-16. PubMed ID: 18514145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.